The global microRNA (miRNA) market has attracted significant attention in recent years, driven by its expanding applications in disease diagnosis, treatment, and biomedical research. According to the latest insights from SkyQuest Technology, the global microRNA market is expected to reach USD 3.58 billion by 2031, growing at a CAGR of 12.9%
- Thermo Fisher Scientific Inc.
- Qiagen National Park
- Merck KGaA
- Illumina Inc.
- Horizon Discovery Group plc
- GeneCopoeia Inc.
- NanoString Technologies, Inc.
- Abcam plc
- New England Biolabs
- Rosetta Genomics, Inc.
